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Abstract The outer membrane phospholipase A (OMPLA) of 
Escherichia coli is one of the few integral outer membrane pro- 
teins displaying enzymatic activity. It is encoded as a mature 
protein of 269 amino acids preceded by a signal sequence of 20 
amino acids. There is no sequence homology with water-soluble 
lipases and phospholipases. Crystals of the mature enzyme were 
obtained at 22°C from 24-28% (v/v) 2-methyl-2,4-pentanediol in 
Bis-Tris buffer, pH 5.9-6.0, with 1 mM calcium chloride and 
1.5% (w/v) ~-octylglucoside. They have the symmetry of the 
trigonal spacegroup P3121 (or P3221) with cell dimensions of 
a = b = 79.6 A and c = 102.8 A (a =/ ]  = 90 °, y = 120°). Native 
crystals diffract to a resolution of 2.6 A. 
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1. Introduction 
Most bacterial outer membrane proteins are involved in the 
transport of nutrients and ions by forming pores or receptors. 
The outer membrane phospholipase A (OMPLA; also desig- 
nated PldA protein, after its structural genepldA, or detergent- 
resistant phospholipase A) of Escherichia coli is one of the few 
enzymes present in the outer membrane. The exact function of 
OMPLA is unknown. It displays a Ca2+-dependent hydrolytic 
activity towards both phospholipids and lipids [1-3]. High ac- 
tivity is induced when the outer membrane is damaged, e.g. by 
phage-induced lysis [4] or temperature shock [5]. It is obvious 
that the E. coli OMPLA and all other membrane phosphoti- 
pases, embedded in their own substrate, require a very strict 
regulatory mechanism for their enzymatic activity to prevent 
unwanted lysis of the cell envelope. In normally growing cells 
OMPLA seems to be dormant and E. coli mutants missing the 
pldA gene are normally viable under laboratory conditions, 
which suggests that the protein has no essential role [6]. Never- 
theless, OMPLA might be important for growth of the bacteria 
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in their natural environment since it occurs widespread and is 
well-conserved among Enterobacteriaceae, including patho- 
genic species [6]. 
The pldA genes from several Enterobacteriaceae have been 
cloned [5-7]. OMPLAs show no sequence homology to water- 
soluble (phospho)lipases and do not contain any cysteine resi- 
dues. The E. coli gene codes for a 30-kDa mature protein of 269 
amino acid residues preceded by a signal sequence of 20 amino 
acid residues. The signal sequence is essential for translocation 
of the protein across the inner membrane, after which OMPLA 
folds and inserts into the outer membrane. The mature OM- 
PLAs of E. coli, Salmonella typhimurium, Klebsiella pneumoniae 
and Proteus vulgaris are highly homologous, with 79% of the 
amino acid residues being identical in all four proteins [6]. Like 
porins, OMPLA lacks long hydrophobic segments which could 
span the outer membrane in an a-helix conformation [6,7]. A 
topology model has been proposed [6] that predicts a fl-barrel 
structure analogous to the porins for which the structure has 
been solved by X-ray diffraction [8-10]. Circular dichroism 
spectroscopy indeed revealed a very high content offl-strands 
in E. coli OMPLA [11]. To establish the details of the topology 
and the reaction and activation mechanism of OMPLA, knowl- 
edge of the three-dimensional structure is essential. 
Crystallization of membrane proteins is a great challenge, 
and not many successful crystallizations have been published, 
let alone successful structure determinations. Although in the 
past crystals of OMPLA from E. coli have been reported [12] 
a structure determination was not possible because of high 
anisotropy in the resolution of the diffraction pattem. Since 
then the overexpression a d purification of lipopolysaccharide- 
free OMPLA from E. coli have been substantially improved 
[11], making it worth to reinvestigate he crystallization proto- 
col. Here we report the successful crystallization of OMPLA 
from E. coil Determination of the crystal structure will provide 
insight into the catalytic mechanism, calcium dependence and 
substrate specificity of this lipolytic enzyme. Data on the regu- 
lation of OMPLA activity can be of general interest o the 
understanding of the regulatory mechanisms in or at biological 
membranes. 
2. Materials and methods 
2.1. Protein purification 
Recombinant OMPLA from E. coli without its signal sequence was 
overexpressed and purified as described [11]. As a result of the cloning 
strategy the protein has an N-terminal extension of six amino acid 
residues (Ala-Arg-Ile-Arg-Ala-Pro). The protein accumulated ininclu- 
sion bodies, but could be refolded in vitro efficiently in the presence of 
0.65% Triton X-100 (Serva). After purification to homogeneity by ion- 
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exchange chromatography, lipopolysaccharide-free OMPLA was con- 
centrated in a Centricon-10 microconcentrator (Amicon) and subse- 
quently dialyzed for one week at 4°C against abuffer containing 10 mM 
sodium succinate at pH 6.0, 1 mM sodium azide and 1.0% (w/v)fl- 
octylglucoside (Boehringer). The protein solution used for crystalliza- 
tion contained pure OMPLA at a concentration f 8 mg/ml and the 
concentration f the detergent was adjusted to 1.5% (w/v). 
2.2. Crystallization 
Crystallization was carried out by the hanging-drop vapour diffusion 
technique at 22°C. Drops were prepared by mixing 3/A of protein 
solution with 2 ~tl of the reservoir solution. All reservoir solutions 
contained calcium chloride as an additive. Based on results obtained 
by Gros et al. [12] initial crystallization experiments were performed 
with 15-30% (v/v) 2-methyl-2,4-pentanediol (MPD; Fluka). The pH 
was screened over a range from 5.5 to 7.0 and the effect of 1, 2, 3 and 
10 mM calcium chloride examined. Subsequently the high melting- 
point isomer of heptane-l,2,3-triol (Oxyl), polyethyleneglycol 400 
(PEG 400; Merck) and sodium chloride were tested as additives. 
2.3. X-Ray diffraction experiments 
All glassware used for mounting of the crystals was siliconized. X- 
Ray studies were done in house at 18°C on a FAST area detector or 
on a MacScience image plate system connected to an Elliot GX-21 
rotating anode, with crystals mounted in thin walled glass capillary 
tubes. Cryogenic data collection using flash-frozen crystals was carried 
out in house on a FAST area detector as well. FAST data were proc- 
essed using the program MADNES [13], image plate data using 
DENZO (Z. Otwinowski, Yale University). Merging of data was done 
with programs from the BIOMOL package (Protein Crystallography 
Group, University of Groningen). 
3. Results and discussion 
Recently, the overexpression a d purification of lipopolysac- 
charide-free OMPLA from E. coli have been substantially im- 
proved [11] and the crystallization protocol [12] has been rein- 
vestigated. This allowed for reproducible formation of well- 
ordered three-dimensional crystals amenable to X-ray struc- 
tural analysis. 
The conditions used so far to crystallize membrane proteins 
employed either PEG or high salt concentrations a crystalliz- 
ing agents [8,9,14-20]. OMPLA from E. coli is the first mem- 
brane protein crystallized using an organic solvent such as 
MPD as crystallizing agent. Hexagonal rod-like crystals appear 
within 1-4 weeks of equilibrium and reach a typical size of 
0.25 x 0.25 x 0.60 mm 3 after 3 weeks. The best crystals are ob- 
tained at 22°C with reservoir solutions containing 24-28% (v/v) 
MPD, 100 mM bis(2-hydroxyethyl)imino-tris(hydroxy- 
methyl)methane (Bis-Tris; Sigma) at pH 5.9 or 6.0 and 1 mM 
calcium chloride. All reservoir solutions contain calcium chlo- 
ride as an additive, because of its necessity for the activity of 
the protein. The concentration of calcium chloride has a dis- 
tinct effect on the crystallization behaviour of OMPLA. We 
observe that in the presence of 2, 3 and 10 mM calcium chloride 
only needle-like microcrystals appear. The addition of sodium 
chloride or heptane-l,2,3-triol s not beneficial for crystalliza- 
tion, whereas the addition of 1%, 2% or 3% (v/v) of PEG 400 
increases the number of crystals about two- fold without affect- 
ing their dimensions. The crystals are stable for at least one 
month in a solution containing a 1% or 2% (v/v) higher MPD 
concentration than the reservoir solution to which the drop had 
been equilibrated, 100 mM Bis-Tris at pH 6.0, 0 or 3% (v/v) 
PEG 400 and 1 mM calcium chloride. 
At 18°C the crystals are resistant to radiation damage for at 
least 30 h in the X-ray beam generated by the rotating anode. 
The crystals belong to the trigonal spacegroup P3121 (or P3221) 
with unit cell dimensions of a = b = 79.6 A and c = 102.8 
(c~ =f l  = 90 °, y = 120°). The presence of 1% or 3% PEG 400 
during crystallization has no influence on the cell dimensions. 
The spacegroup contains six asymmetric units per unit cell. 
Given the monomer molecular weight of 30 kDa, a packing 
with one molecule per asymmetric unit is most likely since this 
corresponds to a Matthews coefficient (VM) [21] of 3.2 A3/Da 
and 61% solvent content. This agrees well with values obtained 
for other membrane proteins [8,9,15 19], ranging from a V M of 
2.5 ~3/Da (51% solvent content) for crystals of a light-harvest- 
ing complex [19] to a V M of 5.2/~3/Da (76% solvent content) 
for crystals of maltoporin from E. coli [16]. 
Several native datasets have been collected in-house at 18°C 
from crystals formed both in the absence and in the presence 
of 1% or 3% (v/v) PEG 400 during crystallization. The best 
datasets are 95% complete to 2.9 and 2.8 A resolution, repec- 
tively. So far, cryogenic data collection with a crystal directly 
taken from the stabilizing mother liquor has been performed 
once and seems to yield a data set of a slightly higher esolution 
with cell dimensions shrunken to a = b = 78.5 A and c = 101.6 
/~(~=]3=90 ° , y= 120 °). 
Determination of the crystal structure of OMPLA from 
E. coli should provide insight into its catalytic mechanism, 
calcium dependence and substrate specificity, and into the to- 
pology of this intriguing membrane protein as well. With the 
procedures now established, crystals of OMPLA from E. coli, 
amenable to X-ray structure analysis, can be obtained repro- 
ducibly. A search for heavy-atom derivatives i  in progress. 
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